Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04807374 · ClinicalTrials.gov registry record · NA

Hybrid Closed Loop in High Risk Youth With Type 1 Diabetes

A NA study, sponsored by Children's National Research Institute.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT04807374 is a NA study that has completed, run by Children's National Research Institute. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04807374, a NA study, has completed, sponsored by Children's National Research Institute.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The use of insulin pumps and continuous glucose monitors for Type 1 diabetes (T1D) has been shown to improve glycemic control while also decreasing the risk for acute and chronic complications. Unfortunately, there are vast disparities in access to this technology; non-Hispanic black youth with public healthcare insurance are the least likely to have access to these technologies. We propose to conduct a non-randomized interrupted time series study to assess the impact of hybrid closed loop (HCL) insulin delivery in underserved youths with poorly controlled T1D. Patients will complete standard diabetes education before beginning to use this technology and will be followed for 6-months after starting HCL to assess its impact on glycemic control and health-related quality of life.

Interventions

  • DEVICE Control IQ

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-06-01
Est. Completion 2023-06-22
Phase NA

What the Registry Record Tells You About NCT04807374

The ClinicalTrials.gov registry entry for NCT04807374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Control IQ is the first listed.

NCT04807374 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04807374 about?

NCT04807374 is a clinical study titled "Hybrid Closed Loop in High Risk Youth With Type 1 Diabetes". The use of insulin pumps and continuous glucose monitors for Type 1 diabetes (T1D) has been shown to improve glycemic control while also decreasing the risk for acute and chronic complications. Unfortunately, there are vast disparities in access to this technology; non-Hispanic black youth with publ...

What is the current status of trial NCT04807374?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-06-01. Estimated completion is 2023-06-22.

What interventions are being tested in trial NCT04807374?

The interventions under investigation include: Control IQ (DEVICE).

Who is sponsoring clinical trial NCT04807374?

This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.